Cold probe treatment for brain tumors
Part of Brain & nervous system, Cancer clinical trials.
This trial tests a cold-based treatment (cryoablation) for certain brain tumors including gliomas, meningiomas, and metastases. It may be an option if you plan to have surgery and meet safety criteria.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old
- Your tumor is likely a glioma, meningioma, or brain metastasis
- The tumor is in a safe location to treat with a cold probe
- You have a good performance level (able to do daily activities)
- You can understand Dutch well enough to discuss the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests giving targeted radiation while surgeons are operating to treat brain metastases. It may help control the cancer locally at the time of surgery, especially for certain single lesions.
This study tests a freezing treatment called cryoablation for early-stage breast cancer in people aged 70 and older. It aims to see if freezing the tumor can be a safe and effective alternative to surgery for those who may be older or frail.
This trial tests whether freezing the main breast tumor (cryoablation) can help people with metastatic breast cancer whose cancer elsewhere is stable or responding to treatment but the breast tumor is growing. It aims to see if this approach is safe and beneficial.
This trial tests cryoablation (freezing the tumor with a needle) as a way to treat small, low-risk breast cancers without surgery. It is for women 50 or older whose cancers are hormone-receptor-positive and haven't spread to lymph nodes.
This trial is studying the use of a freezing treatment called cryoablation to completely destroy bone tumors that have spread from other cancers. It is for people who have only a few tumors or whose tumors are mostly stable, and who are healthy enough to undergo the procedure.
This trial tests a treatment for early-stage lung cancer (stage I-IIA) that uses extreme cold to freeze and destroy the tumor, called cryoablation. Some patients will also receive an immunotherapy drug called serplulimab, which helps the immune system fight the cancer, to see if adding it improves outcomes.
Hear when a new Brain Metastases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.